| 1 |
nuclear factor kappa B
(813 times)
|
Biochemistry
(76 times)
|
TNF-alpha (105 times)
LPS (71 times)
COX-2 (52 times)
|
1992 Reduced susceptibility to HIV-1 infection of ethyl-methanesulfonate-treated CEM subclones correlates with a blockade in their protein kinase C signaling pathway.
|
| 2 |
nuclear factor kappa-light-chain-enhancer of activated B cells
(113 times)
|
Chemistry
(13 times)
|
TNF-alpha (17 times)
LPS (13 times)
IL-1beta (12 times)
|
2010 Very low frequencies of Toll-like receptor 2 supposed-2029T and 2258A (RS5743708) mutant alleles in southern Brazilian critically ill patients: would it be a lack of worldwide-accepted clinical applications of Toll-like receptor 2 variants?
|
| 3 |
nuclear factor kappa-B
(108 times)
|
Biochemistry
(14 times)
|
TNF-alpha (15 times)
Nrf2 (11 times)
IL (7 times)
|
2000 Nuclear Factor Kappa-B Activation by Particles and Fibers.
|
| 4 |
nuclear transcription factor kappa B
(30 times)
|
Pharmacology
(6 times)
|
LPS (6 times)
TNF-alpha (5 times)
IL (3 times)
|
1995 Bionutrition and oral cancer in humans.
|
| 5 |
nuclear factor-k-gene binding
(7 times)
|
Cell Biology
(2 times)
|
LPS (2 times)
AKT1 (1 time)
CASP8 (1 time)
|
2006 Intestinal ischemic preconditioning in rats and NF-kappaB activation.
|
| 6 |
nuclear factor kappa light polypeptide gene enhancer in B cells
(2 times)
|
Rheumatology
(1 time)
|
DAG (1 time)
EDL (1 time)
Epit (1 time)
|
2006 Lack of association of a functional -94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in northwest Spain.
|
| 7 |
nuclear factor kappa-B cells
(2 times)
|
Biological Science Disciplines
(1 time)
|
absolute EtOH (1 time)
COX-2 (1 time)
DPPH (1 time)
|
2016 Anti-inflammatory effects of royal poinciana through inhibition of toll-like receptor 4 signaling pathway.
|
| 8 |
transcriptional factor-kappa B
(2 times)
|
Lipids
(1 time)
|
CAT (1 time)
Con A (1 time)
DM-CMP (1 time)
|
2010 The therapeutic effect of DA-6034 on ocular inflammation via suppression of MMP-9 and inflammatory cytokines and activation of the MAPK signaling pathway in an experimental dry eye model.
|
| 9 |
new regulatory link between the first
(1 time)
|
Medicine
(1 time)
|
ART (1 time)
|
2004 Molecular mechanisms involved in HIV-1 transcriptional latency and reactivation: implications for the development of therapeutic strategies.
|
| 10 |
NF-kB and TATA box oligonucleotides, but distamycin
(1 time)
|
Drug Therapy
(1 time)
|
BIA (1 time)
SPR (1 time)
|
2000 Biospecific interaction analysis (BIA) of low-molecular weight DNA-binding drugs.
|
| 11 |
nuclear factor kappa B pathway
(1 time)
|
Hematology
(1 time)
|
S1P (1 time)
S1PR2 (1 time)
|
2013 Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation.
|
| 12 |
nuclear factor kappa B transcription factor
(1 time)
|
Allergy and Immunology
(1 time)
|
AMP (1 time)
|
2020 Azadirachtin interferes with basal immunity and microbial homeostasis in the Rhodnius prolixus midgut.
|
| 13 |
nuclear factor kappa beta activity
(1 time)
|
Biochemistry
(1 time)
|
ADHD (1 time)
ATX (1 time)
|
2020 Alternations in nuclear factor kappa beta activity (NF-kB) in the rat brain due to long-term use of atomoxetine for treating ADHD: Invivo and in silico studies.
|
| 14 |
nuclear factor of kappa light chain enhancer in B cells
(1 time)
|
Genetics, Medical
(1 time)
|
TNF-alpha (1 time)
|
2012 Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis.
|
| 15 |
nuclear factor of transcription kappa B
(1 time)
|
Cardiology
(1 time)
|
CAD (1 time)
CSI (1 time)
FC (1 time)
|
2018 Quercetin reduces the transcriptional activity of NF-kB in stable coronary artery disease.
|
| 16 |
nuclear factor-kappa light chain, the triggered B cells
(1 time)
|
Biomimetics
(1 time)
|
LPS (1 time)
|
2017 Biosynthesis of cerium oxide nanoparticles and their effect on lipopolysaccharide (LPS) induced sepsis mortality and associated hepatic dysfunction in male Sprague Dawley rats.
|
| 17 |
nuclear factor-kappaBmediated signals
(1 time)
|
|
NSAIDs (1 time)
|
2022 Potential of Anti-inflammatory Molecules in the Chemoprevention of Breast Cancer.
|
| 18 |
nuclear-factor-kappa-B responsive element
(1 time)
|
Communicable Diseases
(1 time)
|
FH (1 time)
MD (1 time)
SNP (1 time)
|
2006 Factor H, a regulator of complement activity, is a major determinant of meningococcal disease susceptibility in UK Caucasian patients.
|
| 19 |
phosphorylated-nuclear factor-kappa B
(1 time)
|
Chemistry
(1 time)
|
---
|
2022 Zileuton, a 5-Lipoxygenase Inhibitor, Attenuates Haemolysate-Induced BV-2 Cell Activation by Suppressing the MyD88/NF-kappaB Pathway.
|
| 20 |
receptors-Nuclear factor kappa B
(1 time)
|
Allergy and Immunology
(1 time)
|
Nrf2 (1 time)
|
2022 Regulation of innate immunity by Nrf2.
|
A Search Service for Abbreviation / Long Form